West nile virus and blood product safety in Germany

Journal of Medical Virology

Volumn 80, Issue 3, 2008, Pages 557-563

  Pfleiderer, Christa ^a   Blümel, Johannes ^a   Schmidt, Michael ^b   Roth, W Kurth ^b   Houfar, M Kai ^b   Eckert, Jana ^b   Chudy, Michael ^a   Menichetti, Eva ^c   Lechner, Sigrid ^d   Nübling, C Micha ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c Institut Wien   (Austria)

^d Institut Klagenfurt   (Austria)

Author keywords

Anti WNV IgG ELISAs; Blood safety; Plasma derivatives; Virus inactivation; West Nile Virus; WNV neutralization

Indexed keywords

BLOOD DERIVATIVE;

AFRICA; ANIMAL CELL; ARTICLE; ASIA; BLOOD DONOR; BLOOD TRANSFUSION; EPIDEMIC; EUROPE; FLAVIVIRUS; GERMANY; HUMAN; MENINGOENCEPHALITIS; MIDDLE EAST; NONHUMAN; NORTH AMERICA; ORGAN TRANSPLANTATION; SAFETY; UNITED STATES; VIRUS INACTIVATION; VIRUS NEUTRALIZATION; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS;

ANTIBODIES, VIRAL; BLOOD BANKS; BLOOD DONORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GERMANY; HUMANS; INCIDENCE; PLASMA; PREVALENCE; REFERENCE STANDARDS; RNA, VIRAL; SAFETY; SENSITIVITY AND SPECIFICITY; VIRUS INACTIVATION; WEST NILE FEVER; WEST NILE VIRUS;

FLAVIVIRUS; WEST NILE VIRUS;

EID: 38849104431     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21110     Document Type: Article

References (22)

1. Allwinn R, Doerr HW, Emmerich P, Schmitz H, Preiser W. 2002. Cross-reactivity in flavivirus serology: New implications of an old finding? Med Microbiol Immunol 190:199-202.
2. Bakonyi T, Hubalek Z, Rudolf I, Nowotny N. 2005. Novel flavivirus or new lineage of West Nile virus, central Europe. Emerg Infect Dis 11:225-231.
3. Bakonyi T, Ivanics E, Erdelyi K, Ursu K, Ferenczi E, Weissenbock H, Nowotny N. 2006. Lineage 1 and 2 strains of encephalitic West Nile virus, central Europe. Emerg Infect Dis 12:618-623.
4. Biggerstaff BJ, Petersen LR. 2002. Estimated risk of West Nile transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion 42:1019-1026.
5. Busch MP, Caglioti S, Robertson EF, McAuley JD, Tobler LH, Kamel H, Linnen JM, Shyamala V, Tomasulo P, Kleinman SH. 2005. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. N Engl J Med 353:460-467.
6. Busch MP, Tobler LH, Saldana J, Caglioti S, Shyamala V, Liinen JM, Phleps B, Smith RI, Drebot M, Kleinman SH. 2005. Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003. Transfusion 45:492-499.
7. Centers for Disease Control and Prevention (CDC). 2006. http://www.cdc.gov/ncidod/dvbid/westnile/index.htm, accessed at October 23, 2006.
8. Gallian P, De Micco P, de Lamballerie X, Levayer T, Levacon F, Guntz P, Mercier B, Dupond I, Cornillot C, Andreu G. 2005. Prevention of West Nile virus Transmission by blood transfusion: A comparison of NAT Screening assays. Transfusion 45:1540-1541.
9. Hollinger FB, Kleinman S. 2003. Transfusion transmission of West Nile virus: A merging of historical and contemporary perspectives. Review. Transfusion 43:992-997.
10. Iwamoto M, Jernigan DB, Guasch A, Trepka MJ, Blackmore CG, Hellinger WC, Pham SM, Zaki S, Lanciotti RS, Lance-Parker SE, DiazGranados CA, Winquist AG, Perlino CA, Wiersma S, Hillyer KL, Goodman JL, Marfin AA, Chamberland ME, Peterson LR. 2003. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 348:2196-2203.
11. Koppelman MH, Sjerps MS, de Waal M, Reesink HW, Cuypers HT. 2006. No evidence of West Nile virus infection in Dutch blood donors. Vox Sang 90:166-169.
12. Koraka P, Zeller H, Niedrig M, Osterhaus ADME, Groen J. 2002. Reactivity of serum samples from patients with a flavivirus infection measured by immunoflorescence assay and ELISA. Microbes Infec 4:1206-1215.
13. Kreil TR, Berting A, Kistner O, Kindermann J. 2003. West Nile virus and the safety of plasma derivatives: Verification of high safety margins, and the validity of predictions based on model virus data. Transfusion 43:1023-1028.
14. Kundi M. 1999. One-hit models for virus inactivation studies. Antiviral Res 41:145-152.
15. Lanciotti RS, Roehrig JT, Deubel V, Smith J, Parker M, Steele K, Crise B, Volpe KE, Crabtree MB, Scherret JH, Hall RA, MacKenzie JS, Cropp CB, Panigrahy B, Ostlund E, Schmitt B, Malkinson M, Banet C, Weissman J, Komar N, Savage HM, Stone W, McNamara T, Gubler DJ. 1999. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286:2333-2337.
16. Lelie PN, van Drimmelen HA, Cuypers HT, Best SJ, Stramer SL, Hyland C, Allain JP, Moncharmont P, Defer C, Nubling M, Glauser A, da Silva Cardoso M, Viret JF, Lankinen MH, Grillner L, Wirthmuller U, Coste J, Schottstedt V, Masecar B, Dax EM. 2002. Sensitivity of HCV RNA and HIV RNA blood screening assays. Transfusion 42:527-536.
17. MMWR. 2002. Possible West Nile virus transmission to an infant through breast feeding, Michigan. MMWR 51:877-878.
18. Niedrig M, Linke S, Zeller H, Drosten C. 2006. First international proficiency study on West Nile virus molecular detection. Clin Chem 52:1851-1854.
19. Petersen LR, Marfin AA. 2002. West Nile virus: A primer for clinician. Ann Intern Med 137:173-179.
20. Solomon T, Ooi MH, Beasley DW, Mallewa M. 2003. West Nile encephalitis. BMJ 326:865-869.
21. Stramer SL, Fang CT, Foster GA, Wagner AG, Brodsky JP, Dodd RY. 2005. West Nile virus among blood donors in the United States, 2003 and 2004. N Engl J Med 353:451-459.
22. Zeller HG, Schuffenecker I. 2004. West Nile Virus. An overview of its spread in Europe and in the Mediterranean Basin in contrast to its spread in the Americas. Eur J Clin Microbiol Infect Dis 23:147-156.